T1	PROC 1 27	Estudio de bioequivalencia
#1	AnnotatorNotes T1	C3640120; Clinical Bioequivalence or Bioavailability Study; Research Activity
T2	CHEM 31 42	montelukast
#2	AnnotatorNotes T2	C0298130; montelukast; Organic Chemical · Pharmacologic Substance
T3	CHEM 868 875	Amisped
T4	CHEM 1732 1739	Amisped
T5	CHEM 113 135	medicamentos genéricos
#3	AnnotatorNotes T5	C0085155; Generic Drugs; Pharmacologic Substance
T6	PROC 302 314	tratamientos
#4	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 347 374	estudios de bioequivalencia
#5	AnnotatorNotes T7	C3640120; Clinical Bioequivalence or Bioavailability Study; Research Activity
T8	CHEM 517 535	montelukast sódico
#6	AnnotatorNotes T8	C0380447; montelukast sodium; Organic Chemical · Pharmacologic Substance
T9	PROC 558 568	profilaxis
#7	AnnotatorNotes T9	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T10	PROC 574 585	tratamiento
T11	DISO 598 602	asma
#8	AnnotatorNotes T11	C0004096; Asthma; Disease or Syndrome
T12	DISO 701 720	reacciones adversas
#9	AnnotatorNotes T12	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T13	CHEM 781 788	fármaco
#10	AnnotatorNotes T13	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T14	CHEM 878 889	montelukast
#11	AnnotatorNotes T14	C0298130; montelukast; Organic Chemical · Pharmacologic Substance
T15	CHEM 962 971	Singulair
#12	AnnotatorNotes T15	C0595724; Singulair; Organic Chemical · Pharmacologic Substance
T16	CHEM 974 985	montelukast
#13	AnnotatorNotes T16	C0298130; montelukast; Organic Chemical · Pharmacologic Substance
T17	CHEM 1135 1146	montelukast
#14	AnnotatorNotes T17	C0298130; montelukast; Organic Chemical · Pharmacologic Substance
T18	PROC 1261 1301	cromatografía líquida de alta resolución
#15	AnnotatorNotes T18	C0008562; High pressure liquid chromatography procedure; Laboratory Procedure
T19	CHEM 1340 1348	genérico
#16	AnnotatorNotes T19	C0085155; Generic Drugs; Pharmacologic Substance
T20	CHEM 1808 1817	Singulair
#17	AnnotatorNotes T20	C0595724; Singulair; Organic Chemical · Pharmacologic Substance
T21	PROC 765 773	tratados
#18	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 835 864	Comparar la biodisponibilidad
#19	AnnotatorNotes T22	C3640120; Clinical Bioequivalence or Bioavailability Study; Research Activity
T23	PROC 445 451	prueba
#20	AnnotatorNotes T23	C0678323; experimentation; Research Activity
T24	PROC 800 820	tratados con placebo
#21	AnnotatorNotes T24	C3897898; Placebo Administration; Therapeutic or Preventive Procedure
T25	PROC 1185 1216	diseño cruzado completo al azar
#22	AnnotatorNotes T25	C0150097; Cross-Over Studies; Research Activity + C0034656; Randomization; Research Activity
T26	PROC 1221 1248	bioanálisis de las muestras
T27	Form 46 66	tabletas masticables
#23	AnnotatorNotes T27	C0304290; Chewable Tablet; Biomedical or Dental Material
T28	Dose 70 74	5 mg
T32	PHYS 412 428	farmacocinéticos
#24	AnnotatorNotes T32	C0031327; Drug Kinetics; Physiologic Function
T33	Duration 586 593	crónico
#25	AnnotatorNotes T33	C0205191; chronic; Temporal Concept
T34	LIVB 607 614	adultos
#26	AnnotatorNotes T34	C0001675; Adult; Age Group
T35	LIVB 617 638	pacientes pediátricos
#27	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T36	Age 642 664	12 meses de edad o más
T37	LIVB 755 764	pacientes
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Form 893 913	tabletas masticables
#29	AnnotatorNotes T38	C0304290; Chewable Tablet; Biomedical or Dental Material
T39	Dose 917 921	5 mg
T40	Form 989 1009	tabletas masticables
#30	AnnotatorNotes T40	C0304290; Chewable Tablet; Biomedical or Dental Material
T41	Dose 1013 1017	5 mg
T29	PHYS 1122 1131	absorción
#31	AnnotatorNotes T29	C0678745; drug absorption; Physiologic Function
T30	LIVB 1153 1170	voluntarios sanos
#32	AnnotatorNotes T30	C1708335; Healthy Volunteers; Population Group
T31	ANAT 1240 1248	muestras
#33	AnnotatorNotes T31	C2347026; Biospecimen; Body Substance
T43	Duration 1403 1412	2,17±0,73
T44	Duration 1415 1424	2,28±0,88
A1	Population_data T34 Age
A2	Population_data T35 Age
R1	Has_Drug_Form Arg1:T2 Arg2:T27	
R2	Has_Dose_or_Strength Arg1:T2 Arg2:T28	
T42	CONC 167 192	disminución de los costos
#34	AnnotatorNotes T42	C0085550; Cost Savings; Quantitative Concept
T45	Spec_cue 149 163	posibilidad de
A3	Assertion T42 Speculated
R3	Speculation Arg1:T45 Arg2:T42	
R5	Used_for Arg1:T5 Arg2:T6	
R6	Used_for Arg1:T8 Arg2:T9	
R7	Used_for Arg1:T8 Arg2:T10	
R8	Has_Duration_or_Interval Arg1:T10 Arg2:T33	
#35	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
R9	Experiences Arg1:T34 Arg2:T11	
R10	Experiences Arg1:T34 Arg2:T10	
R11	Experiences Arg1:T34 Arg2:T9	
R12	Experiences Arg1:T35 Arg2:T11	
R13	Has_Age Arg1:T35 Arg2:T36	
R14	Experiences Arg1:T35 Arg2:T10	
R15	Experiences Arg1:T35 Arg2:T9	
T46	Observation 681 694	bien tolerado
R16	Experiences Arg1:T37 Arg2:T12	
R17	Experiences Arg1:T37 Arg2:T46	
R18	Experiences Arg1:T37 Arg2:T21	
R19	Used_for Arg1:T13 Arg2:T21	
R20	Causes Arg1:T21 Arg2:T12	
R21	Causes Arg1:T24 Arg2:T12	
R22	Experiences Arg1:T37 Arg2:T24	
R23	Has_Drug_Form Arg1:T3 Arg2:T38	
R24	Has_Drug_Form Arg1:T14 Arg2:T38	
R25	Has_Dose_or_Strength Arg1:T14 Arg2:T39	
R26	Has_Dose_or_Strength Arg1:T15 Arg2:T41	
R27	Has_Drug_Form Arg1:T16 Arg2:T40	
R28	Has_Dose_or_Strength Arg1:T16 Arg2:T41	
R29	Has_Drug_Form Arg1:T15 Arg2:T40	
R30	Has_Dose_or_Strength Arg1:T3 Arg2:T39	
R31	Experiences Arg1:T30 Arg2:T29	
T47	CONC 1092 1131	magnitud y la velocidad de la absorción
R32	Used_for Arg1:T17 Arg2:T29	
R33	Experiences Arg1:T30 Arg2:T17	
T48	CONC 1390 1394	Tmax
#36	AnnotatorNotes T48	C2348796; Tmax; Quantitative Concept
R36	Has_Duration_or_Interval Arg1:T48 Arg2:T43	
R37	Has_Duration_or_Interval Arg1:T48 Arg2:T44	
T49	CONC 1426 1430	Cmax
#37	AnnotatorNotes T49	C2347813; Cmax; Quantitative Concept
T50	CONC 1470 1476	AUC0-t
T51	CONC 1524 1530	AUC0-∞
T52	Quantifier_or_Qualifier 1762 1776	bioequivalente
#38	AnnotatorNotes T52	C0039789; Therapeutic Equivalency; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T52	
T53	CONC 403 428	perfiles farmacocinéticos
#39	AnnotatorNotes T46	C5684674; patient tolerated procedure well; Finding
R39	Overlap Arg1:T46 Arg2:T21	
R4	Experiences Arg1:T35 Arg2:T8	
R40	Experiences Arg1:T34 Arg2:T8	
#40	AnnotatorNotes T53	C0031328; Pharmacokinetic aspects; Functional Concept
A4	Experiencer T34 Patient
A5	Experiencer T35 Patient
A6	Experiencer T37 Patient
A7	Experiencer T30 Patient
